Brief: eFFECTOR Therapeutics Q1 Net Income USD -8.834 Million
May 09 (Reuters) - eFFECTOR Therapeutics Q1 basic EPS USD -2.16. * Q1 operating expenses USD 8.396 million * Q1 operating income USD -8.396 million
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright